Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Chemmedchem|April 26, 2017
Immunogenicity of a Fully Synthetic MUC1 Glycopeptide Antitumor Vaccine Enhanced by Poly(I:C) as a TLR3-Activating AdjuvantMarkus Glaffig, Natascha Stergiou, Edgar Schmitt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 7, 2007
Dendritic cell-based immunotherapy of malignant melanoma: success and limitationsAndrea Tuettenberg, Edgar Schmitt, Jürgen Knop, et al.
Cancer Immunology, Immunotherapy : CII|April 3, 2010
New strategies for the manipulation of adaptive immune responsesTobias Bopp, Markus Radsak, Edgar Schmitt, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2005
Activation of mast cells by streptolysin O and lipopolysaccharideMichael Stassen, Angela Valeva, Iwan Walev, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 8, 2017
Messenger RNA Sequencing of Rare Cell Populations in the Lung and Lung-Draining Lymph NodesAlexander Ulges, Edgar Schmitt, Tobias Bopp, et al.
Chemical Communications (Cambridge, England)|September 11, 2010
Perfluoroalkylated amphiphilic MUC1 glycopeptide antigens as tools for cancer immunotherapyAnja Hoffmann-Röder, Jérôme Schoenhentz, Sarah Wagner, et al.
Medical Microbiology and Immunology|May 23, 2006
Regulatory T cells: present facts and future hopesChristian Becker, Sabine Stoll, Tobias Bopp, et al.
Chemmedchem|December 2, 2017
A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic CellsMarkus Glaffig, Natascha Stergiou, Sebastian Hartmann, et al.
Pageof 12